EX-10.2

Exhibit 10.2

FifteenthAmendment To

WholesaleProductPurchaseAgreement

ThisFifteenthAmendmenttoWholesaleProductPurchaseAgreement(this“Fifteenth Amendment”)ismadeasofthelastdatePartyexecutesthisFifteenthAmendment(the“Amendment EffectiveDate”),byandbetweenPriorityHealthcareDistribution,Inc.,doingbusinessasCuraScriptSD Specialty Distribution, a Florida corporation having offices at 255 Technology Park, Lake Mary, Florida 32746, (“Distributor”), and United Therapeutics Corporation (“UT”), a Delaware public benefit corporation having offices at 1040 Spring Street, Silver Spring, Maryland. Distributor and UT are each referred to in this Agreement as a “Party,” collectively, the “Parties.”

WHEREAS,thePartiesenteredintothatcertainWholesaleProductPurchaseAgreement(asamended, the “Agreement”), dated as of January 1, 2018, providing for the distribution of Remodulin® (treprostinil) Injection (“Remodulin”), among other products;

Whereas, the Parties now wish to amend the Agreement as provided herein, with effect as of the Amendment Effective Date.

Now therefore, in consideration of the mutual agreements and covenants contained herein, and forothergoodandvaluableconsideration,thereceiptandsufficiencyofwhichareherebyacknowledged, the Parties hereto, intending to be legally bound, hereby agree as follows:

1.ExhibitAisherebydeletedinitsentiretyandisreplacedwiththeattachedExhibitA.

2.ExhibitBisherebydeletedinitsentiretyandisreplacedwiththeattachedExhibitB.

3.Exceptasamendedandsupplementedhereby,allofthetermsandconditionsoftheAgreement shall remain and continue in full force and effect and apply hereto.

(SignaturePagetoFollow)

Inwitnesswhereof,eachoftheundersigned,dulyauthorized,hasexecutedthisFifteenth Amendment, effective as of the Amendment Effective Date.